We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Hinge Health, Inc. (HNGE - Free Report) operates a digital musculoskeletal (MSK) care platform designed to transform how arthritis, back pain, joint injuries, and post-surgical rehabilitation are treated. Hinge Health's expanding AI-led care platform supports an Outperform view as rapid growth increasingly translates into higher margins and cash generation. Enrollment gains, member renewals and enterprise distribution reinforce the core MSK business. The growing adoption of Migraine and GI care adds opportunities to deepen client relationships, while HingeSelect extends the platform into hybrid care. Higher guidance reflects better yield and operating discipline, giving the company room to invest while returning capital. HNGE, which went public in May 2025, is projected to double its revenue between 2025 and 2027, and its upward earnings revisions earn Hinge Health a Zacks Rank #1 (Strong Buy). The digital health firm is gaining steam as it expands its corporate clients (+28% YoY in Q3), which offer their employees access to Hinge’s growing number of AI- and wearable-boosted virtual health offerings.
It is also expanding its margins and free cash flow and diversifying far beyond Hinge’s original focus of musculoskeletal care—think arthritis, back pain, and more—through organic initiatives and acquisitions. HNGE raised its fiscal 2026 guidance after the strong report on November 2. Its upward EPS revisions earn it a Zacks Rank #1 (Strong Buy) and extend a strong run of positivity.
Western Digital Corporation (WDC - Free Report) ) develops and manufactures data storage devices and solutions. Western Digital reported better-than-expected fiscal first-quarter sales, margins and free cash flow, led by multi-year customer visibility and a technology-led strategy focused on areal density. Sustained growth in cloud and AI data storage as customers retain more information for longer is a plus. Its high-capacity HDDs offer attractive economics for large-scale storage, while the ePMR ramp and planned HAMR launches expand its ability to meet demand. Longer customer planning horizons improve visibility, and higher prices per terabyte support further margin gains. Strong cash generation, a net cash position and a higher dividend reinforce shareholder returns. Western Digital's fiscal 2026 performance and first-quarter fiscal 2027 results demonstrate how higher-capacity products, favorable pricing and manufacturing discipline are translating demand into greater profitability. Looking at the earnings estimate revisions for Western Digital, the Zacks Consensus Estimate for the current year has increased 20.2% over the past month to $24.36. Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.
Top Stock Picks for Week of November 16, 2026
Hinge Health, Inc. (HNGE - Free Report) operates a digital musculoskeletal (MSK) care platform designed to transform how arthritis, back pain, joint injuries, and post-surgical rehabilitation are treated. Hinge Health's expanding AI-led care platform supports an Outperform view as rapid growth increasingly translates into higher margins and cash generation. Enrollment gains, member renewals and enterprise distribution reinforce the core MSK business. The growing adoption of Migraine and GI care adds opportunities to deepen client relationships, while HingeSelect extends the platform into hybrid care. Higher guidance reflects better yield and operating discipline, giving the company room to invest while returning capital. HNGE, which went public in May 2025, is projected to double its revenue between 2025 and 2027, and its upward earnings revisions earn Hinge Health a Zacks Rank #1 (Strong Buy). The digital health firm is gaining steam as it expands its corporate clients (+28% YoY in Q3), which offer their employees access to Hinge’s growing number of AI- and wearable-boosted virtual health offerings.
It is also expanding its margins and free cash flow and diversifying far beyond Hinge’s original focus of musculoskeletal care—think arthritis, back pain, and more—through organic initiatives and acquisitions. HNGE raised its fiscal 2026 guidance after the strong report on November 2. Its upward EPS revisions earn it a Zacks Rank #1 (Strong Buy) and extend a strong run of positivity.
Western Digital Corporation (WDC - Free Report) ) develops and manufactures data storage devices and solutions. Western Digital reported better-than-expected fiscal first-quarter sales, margins and free cash flow, led by multi-year customer visibility and a technology-led strategy focused on areal density. Sustained growth in cloud and AI data storage as customers retain more information for longer is a plus. Its high-capacity HDDs offer attractive economics for large-scale storage, while the ePMR ramp and planned HAMR launches expand its ability to meet demand. Longer customer planning horizons improve visibility, and higher prices per terabyte support further margin gains. Strong cash generation, a net cash position and a higher dividend reinforce shareholder returns. Western Digital's fiscal 2026 performance and first-quarter fiscal 2027 results demonstrate how higher-capacity products, favorable pricing and manufacturing discipline are translating demand into greater profitability. Looking at the earnings estimate revisions for Western Digital, the Zacks Consensus Estimate for the current year has increased 20.2% over the past month to $24.36. Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.